Study finds AI blood test developed at Johns Hopkins successfully detects liver cancer

How City of Hope is using AI to improve surgical outcomes

With recent leaps in artificial intelligence, there is major potential to turn computing advances into gains for human health.

University Hospitals Cleveland, Qure.ai collaborate on early lung cancer detection

University Hospitals Cleveland Medical Center has announced a collaboration with global healthcare AI company Qure.ai to deploy chest X-ray AI supporting earlier identification of lung cancers.

April 04, 2025

Vol.51 No.13

Clinical Roundup

Researchers identify “master regulator” gene that could lead to more effective ovarian cancer treatment

Researchers have identified a “master regulator” gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research.

April 04, 2025

Vol.51 No.13

In Brief

Karen Knudsen joins Paradigm Health’s board of directors as company prepares launch of AI-driven clinical trial data collection and management application

Paradigm Health announced on March 20 the appointment of Karen E. Knudsen to its board of directors, alongside the upcoming launch of its eSource clinical trial data application.

March 28, 2025

Vol.51 No.12

Guest Editorial

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

Technological innovations are often hailed as transformative tools capable of revolutionizing healthcare. From gene editing for conditions like sickle cell disease to AI predicting hospital readmissions, to telemedicine expanding healthcare access, these advancements have the potential to change the way we treat diseases.

March 21, 2025

Vol.51 No.11

By Jamillah Hoy-Rosas

In Brief

Elana Fertig named associate director for quantitative science at University of Maryland Greenebaum

Elana J. Fertig was named associate director for quantitative science at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.

March 21, 2025

Vol.51 No.11

Study finds AI blood test developed at Johns Hopkins successfully detects liver cancer

YOU MAY BE INTERESTED IN

How City of Hope is using AI to improve surgical outcomes

University Hospitals Cleveland, Qure.ai collaborate on early lung cancer detection

Researchers identify “master regulator” gene that could lead to more effective ovarian cancer treatment

Karen Knudsen joins Paradigm Health’s board of directors as company prepares launch of AI-driven clinical trial data collection and management application

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

Elana Fertig named associate director for quantitative science at University of Maryland Greenebaum

Renew today!

Subscriber content

Never miss an issue!

Login